Heart Consultant: Common Diagnostic Tests And Investigations Explained
Types of Cardiac Diagnostic Tests and Investigations
Surface electrocardiography is often among the first tests used in cardiac assessment. A 12-lead ECG typically takes minutes and can reveal rhythm abnormalities, conduction delays, or changes suggesting ischemia or prior infarction. Ambulatory ECG monitoring—ranging from 24–48 hour Holter systems to longer event recorders—may be applied when symptoms are intermittent. These tools can detect transient arrhythmias that a single resting recording might miss. Clinicians often weigh monitoring duration against symptom frequency to choose an appropriate device and may combine ECG results with symptom diaries for interpretation.
Echocardiography commonly provides real-time visualization of cardiac structure and function. Transthoracic echocardiography (TTE) is non-invasive and often used to estimate ventricular function, assess valve anatomy and regurgitation or stenosis, and detect pericardial effusion. Transesophageal echocardiography (TEE) can be considered when detailed views of posterior structures or valves are needed but typically involves more preparation and sedation. Image quality can be influenced by body habitus and acoustic windows, so clinicians may consider complementary imaging when images are suboptimal.
Stress testing evaluates cardiac response to increased demand and may use exercise or pharmacologic agents. Exercise ECG testing typically assesses for exertional symptoms, ECG changes, and functional capacity. When a patient cannot exercise adequately, pharmacologic stress agents coupled with imaging (echocardiography, nuclear perfusion) can simulate increased myocardial demand. Test selection often reflects clinical goals—detecting ischemia, assessing functional capacity, or evaluating exercise tolerance—and test sensitivity and specificity vary based on modality and patient characteristics.
Cardiac rhythm devices and ambulatory monitors have evolved to include patch-based recorders and implantable loop recorders for long-term surveillance. Patch devices may allow multi-day monitoring with improved patient comfort, while implantable recorders can capture infrequent syncope or arrhythmic events over months to years. Choice of device often depends on symptom frequency, the suspected diagnosis, and consideration of invasiveness versus diagnostic yield. Each option carries trade-offs in monitoring duration, data volume, and patient convenience.